Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Jul 2026

Real‐world implementation of lecanemab in Alzheimer's disease: A Japanese cohort

Abstract INTRODUCTION Real‐world evidence for lecanemab remains limited, particularly among Asian populations. We evaluated the feasibility, safety, biomarker profiles, and short‐term clinical outcomes of lecanemab in practice in Japan. METHODS We screened 321 patients with early Alzheimer's disease (AD) and confirmed...

S. Shimohama, S. Bun, Ryo Shikimoto et al. · 0 citations
Open access Sep 2026

Contribution of copy number variants to schizophrenia in East Asian populations

A significantly elevated genome-wide rare CNV burden in EAS cases compared with controls is observed, underscoring the importance of increasing population diversity to fully capture the genetic underpinnings of schizophrenia.

Yu Chen, Qi-Di Feng, Max Lam et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.